Table 1:
General characteristics, PANSS score, cognition scores and NT-3 levels in schizophrenia spectrum disorders and controls.
| S. No. | Parameter | Control (n=216) | Schizophrenia (n=216) | P |
|---|---|---|---|---|
| 1. | Age (years) | 36.33±8.81 | 35±9.35 | 0.232 |
| 2. | Gender (female/male) | 136/80 | 97/119 | - |
| 3. | Body mass index (kg/m2) | 25.39±3.90 | 25.54±4.14 | 0.697 |
| 4. | Drug naïve/Drug free | - | 119/97 | |
| 5. | Socioeconomic status (upper/lower) | 169/47 | 52/164 | - |
| 6. | NT-3 (ng/L) | 125.25 (94.5–187.72) | 197.50 (133.25–287.0) | 0.0001 |
| 7. | Duration of illness (years) | - | 3 (1–7) | - |
| 8. | Positive symptoms score | - | 15 (10–19.75) | - |
| 9. | Negative symptoms score | - | 16 (11–21) | - |
| 10. | General psychopathological score | - | 28 (21–36) | - |
| 11. | Total PANSS | - | 61.67±22.40 | - |
| 12. | Attention | - | 14 (11–16) | - |
| 13. | Fluency | - | 6 (5–8) | - |
| 14. | Memory | - | 11 (5–18) | - |
| 15. | Language | - | 23 (21–26) | - |
| 16. | Visuospatial abilities | - | 11 (9–14) | - |
| 17. | Total ACE-III | - | 64.63±17.43 | - |
NT-3: Neurotrophin-3, ACE-III: Addenbrooke cognitive examination-III, PANSS: Positive and negative symptom scores